Catholic University of Leuven:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Catholic University of Leuven - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9287
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Catholic University of Leuven (KU Leuven) is a scientific research and educational service provider that provides bachelors degree, post graduate degree and doctorate degree programs. The university provides educational courses in the areas of psychology and educational sciences, arts, law, economics and business, science and medicine, social science, pharmaceutical science, and others. It offers services such as engineering science, architecture, religious studies, bioscience engineering, engineering technology, and others. KU Leuven provides research in areas of human health, medical technologies, bio-sciences and environment, materials and energy, manufacturing and ICT, arts, religion and culture, economy, law and society, and human behaviour, among others. The university operates in Brussels, Ghent and Antwerp, among others. KU Leuven is headquartered in Leuven, Belgium.

Catholic University of Leuven – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Catholic University of Leuven, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Catholic University of Leuven, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Catholic University of Leuven, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Catholic University of Leuven, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Catholic University of Leuven, Medical Devices Deals, 2012 to YTD 2018 9
Catholic University of Leuven, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Catholic University of Leuven, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Agilent Tech Extends its Agreement with University of Leuven – Center for Human Genetics and University Hospitals Leuven 11
Royal Philips Enters into Agreement with Universitaire Ziekenhuizen Leuven 12
Katholieke Universiteit Leuven And Wellcome Trust Enter Into Agreement With Janssen Pharma To Develop Dengue Antiviral Drugs 13
Oncodesign And Laboratory For Neurobiology and Gene Therapy Enter Into Research Agreement With Ipsen For Parkinson’s Disease 15
Licensing Agreements 17
Katholieke Universiteit Leuven Enters Into Licensing Agreement With FIT Biotech For Novel Immunotherapeutics Development 17
Equity Offering 18
Aelin Therapeutics Spin Out from K.U. Leuven, University of Leuven and Flanders Institute for Biotechnology 18
Catholic University of Leuven – Key Competitors 19
Catholic University of Leuven – Key Employees 20
Catholic University of Leuven – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Joint Venture 21
Recent Developments 23
Government and Public Interest 23
May 09, 2018: Scientists uncover new genetic cause of lupus 23
Nov 06, 2017: Helmsley Charitable Trust Awards $52 Million to Support the Global Platform for the Prevention of Autoimmune Diabetes 24
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Catholic University of Leuven, Pharmaceuticals & Healthcare, Key Facts 2
Catholic University of Leuven, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Catholic University of Leuven, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Catholic University of Leuven, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Catholic University of Leuven, Deals By Therapy Area, 2012 to YTD 2018 8
Catholic University of Leuven, Medical Devices Deals, 2012 to YTD 2018 9
Catholic University of Leuven, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Agilent Tech Extends its Agreement with University of Leuven - Center for Human Genetics and University Hospitals Leuven 11
Royal Philips Enters into Agreement with Universitaire Ziekenhuizen Leuven 12
Katholieke Universiteit Leuven And Wellcome Trust Enter Into Agreement With Janssen Pharma To Develop Dengue Antiviral Drugs 13
Oncodesign And Laboratory For Neurobiology and Gene Therapy Enter Into Research Agreement With Ipsen For Parkinson's Disease 15
Katholieke Universiteit Leuven Enters Into Licensing Agreement With FIT Biotech For Novel Immunotherapeutics Development 17
Aelin Therapeutics Spin Out from K.U. Leuven, University of Leuven and Flanders Institute for Biotechnology 18
Catholic University of Leuven, Key Competitors 19
Catholic University of Leuven, Key Employees 20
Catholic University of Leuven, Other Locations 21
Catholic University of Leuven, Subsidiaries 21
Catholic University of Leuven, Joint Venture 21

List of Figures
Catholic University of Leuven, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Catholic University of Leuven, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Catholic University of Leuven, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Catholic University of Leuven, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Catholic University of Leuven, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Catholic University of Leuven, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Catholic University of Leuven, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Catholic University of Leuven, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Catholic University of Leuven, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Catholic University of Leuven:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Innsuites Hospitality Trust:企業の戦略・SWOT・財務分析
    Innsuites Hospitality Trust - Strategy, SWOT and Corporate Finance Report Summary Innsuites Hospitality Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Cantex Mine Development Corp (CD):企業の財務・戦略的SWOT分析
    Summary Cantex Mine Development Corp (Cantex) is a mining and mineral exploration company. The company’s business activities include acquisition, exploration, and development of cobalt, copper, manganese, zinc, gold, nickel, and platinum properties. Its projects comprise Al Hariqah Gold project, Al …
  • Petrochemical Corporation of Singapore (Private) Ltd:企業の戦略的SWOT分析
    Petrochemical Corporation of Singapore (Private) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key comp …
  • Yamaha Corporation (7951):企業の財務・戦略的SWOT分析
    Yamaha Corporation (7951) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Advanced Micro Devices Inc (AMD):企業の財務・戦略的SWOT分析
    Advanced Micro Devices Inc (AMD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Nippon Express Co Ltd (9062):企業の財務・戦略的SWOT分析
    Nippon Express Co Ltd (9062) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Bio Pappel, S.A.B. de C.V.:企業の戦略・SWOT・財務情報
    Bio Pappel, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report Summary Bio Pappel, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Tendril Networks Inc:企業の戦略的SWOT分析
    Tendril Networks Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • De Beers Group Plc:企業の戦略・SWOT・財務情報
    De Beers Group Plc - Strategy, SWOT and Corporate Finance Report Summary De Beers Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Fives:企業の戦略・SWOT・財務情報
    Fives - Strategy, SWOT and Corporate Finance Report Summary Fives - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, provid …
  • Bulgarian Telecommunications Company (VIVACOM):企業の戦略的SWOT分析
    Bulgarian Telecommunications Company (VIVACOM) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitor …
  • Inpex Corp (1605):企業の財務・戦略的SWOT分析
    Inpex Corp (1605) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Medivir AB (MVIR B):企業の財務・戦略的SWOT分析
    Summary Medivir AB (Medivir) is a drug discovery and development company focusing on transformative cancer drugs. The company offers products under development for the treatment of cutaneous T-cell lymphoma, osteoarthritis, solid tumors, hepatocellular carcinoma and RSV-infection. Medivir also provi …
  • American Eagle Outfitters Inc:企業の戦略・SWOT・財務情報
    American Eagle Outfitters Inc - Strategy, SWOT and Corporate Finance Report Summary American Eagle Outfitters Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Steris Corp-医療機器分野:企業M&A・提携分析
    Summary Steris Corp (Steris), formerly Innovative Medical Technologies, a subsidiary of Steris Plc, is a medical device company that offers infection prevention and other procedural products and services. The company offers surgical equipment and image management, sterile processing equipment, surgi …
  • The Akita Bank Ltd:企業の戦略・SWOT・財務情報
    The Akita Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Akita Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • The Wistar Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary The Wistar Institute (Wistar) is a biomedical research institute that carries out medical research and training. The institute performs research in the areas of cancer, infectious diseases, immunology and vaccine development. It also conducts research on genes, gene expression, and DNA biolo …
  • Siemens Medical Solutions USA Inc:医療機器:M&Aディール及び事業提携情報
    Summary Siemens Medical Solutions USA Inc (Siemens Medical USA), a subsidiary of Siemens Healthcare GmbH is a medical device company that designs, develops, manufactures and distributes medical devices and technologies for diagnostic markets. The company offers products in the areas of medical imagi …
  • Themis Bioscience GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Themis Bioscience GmbH (Themis Bioscience) is a biotechnology company that develops prophylactic vaccines for emerging tropical infections. The company develops emerging and specialist indications and vaccines from preclinical to late-stage clinical development phases. It develops novel vacc …
  • Renesola Ltd (SOL):電力:M&Aディール及び事業提携情報
    Summary Renesola Ltd (ReneSola) is a solar project developer and operator of energy efficient products that manufactures polysilicon, monocrystalline and multi crystalline solar wafers; and solar photovoltaic cells and modules. It also develops, builds and sells solar power projects across Europe, N …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆